Capital Fund Management (CFM)
SCLN

Capital Fund Management (CFM)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Capital Fund Management (CFM)’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-21,700
Closed -$222K – 1969
2016
Q3 		$222K Buy
+21,700
New +$236K ﹤0.01% 1474

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Capital Fund Management (CFM)'s SCLN Position: Q4 2016 in Review

Capital Fund Management (CFM) sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 21,700 shares — an estimated $222K sold.

Capital Fund Management (CFM) first reported a position in SCLN in Q3 2016 and held it in 1 quarter. The position peaked at $222K in Q3 2016. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • Capital Fund Management (CFM) reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 21,700 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $222K.
  • Capital Fund Management (CFM) first reported a position in Sciclone Pharmaceuticals Inc in Q3 2016 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Sciclone Pharmaceuticals Inc position peaked at $222K in Q3 2016.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2016, filed 8 Feb 2017.